Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
Drug Saf. 2023 Jun;46(6):517-532.
doi: 10.1007/s40264-023-01285-5.
Epub 2023 May 23.
1 Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland. priya.bahri@ema.europa.eu.
2 European Medicines Agency (EMA) (Coordinator of the ISoP CommSIG in Her Personal Capacity), Domenico Scarlattilaan 6, 1083 HS, Amsterdam, The Netherlands. priya.bahri@ema.europa.eu.
3 Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG), Geneva, Switzerland.
4 Uppsala Monitoring Centre (UMC), Uppsala, Sweden.
5 Husoteria Ltd, Ashtead, UK.
6 West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham, UK.
7 Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, Oxford, UK.
8 Pontificia Universidad Javeriana, Bogotá, Colombia.
9 , Oxford, UK.
10 Department of Clinical Pharmacy and Pharmacology, University of Groningen, Groningen, The Netherlands.
11 Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
12 Takeda, Cambridge, MA, USA.
13 Tunisian National Centre of Pharmacovigilance, Tunis, Tunisia.
14 Israel Society for Medication and Vaccine Safety (ERANIM), Jerusalem, Israel.
15 Pfizer s.r.l., Safety Surveillance and Risk Management, Milan, Italy.
16 Department of Psychology, Social Psychology and Decision Sciences, University of Konstanz, Konstanz, Germany.
17 Department of Pharmaceutical Sciences, University of Kashmir, Srinagar, India.
18 School of Government, Ateneo De Manila University, Quezon City, Philippines.
19 European Organisation for Rare Diseases (EURORDIS), Paris, France.
20 Thai Food and Drug Administration, Health Product Vigilance Center, Bangkok, Thailand.
21 School of Healthcare, University of Leeds, Leeds, UK.
22 Department of Pharmacology, Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
23 Pharmacy Department, Mater Dei Hospital, Msida, Malta.